imiquimod has been researched along with Medulloblastoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aberger, F; Esterbauer, H; Frischauf, AM; Gruber, W; Loipetzberger, A; Wolff, F | 1 |
Reifenberger, J; Schön, MP | 1 |
2 other study(ies) available for imiquimod and Medulloblastoma
Article | Year |
---|---|
Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Hedgehog Proteins; Humans; Imiquimod; Kruppel-Like Transcription Factors; Medulloblastoma; Myeloid Differentiation Factor 88; Nerve Tissue Proteins; Receptors, Purinergic P1; Signal Transduction; Toll-Like Receptor 7; Toll-Like Receptor 8; Transcription Factors; Zinc Finger Protein GLI1; Zinc Finger Protein Gli3 | 2013 |
[Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy].
Topics: Adjuvants, Immunologic; Alleles; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cerebellar Neoplasms; Disease Models, Animal; Genes, Tumor Suppressor; Hedgehog Proteins; Humans; Imiquimod; Medulloblastoma; Membrane Proteins; Mice; Mutation; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface; Signal Transduction; Skin Neoplasms; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Veratrum Alkaloids | 2003 |